Skip to Main Content

Paper Details

Standardized evidence-based approach for assessment of oncogenic and clinical significance of NTRK fusions.
Cancer Genet
3
2022
KANK1, LMNA, NTRK, NTRK fusion, NTRK fusions, NTRK1, NTRK1 and KANK1, NTRK2, NTRK2 fusions, NTRK3, fusion partners, neurotrophic receptor tyrosine kinase genes, patients, pediatric, pediatric and adult tumors, tumor, tyrosine
Author NameAffiliation
Jason SalibaWashington University School of Medicine in St. Louis
Shruti RaoInnovation Center for Biomedical Informatics, Georgetown University Medical Center
Shruti RaoInnovation Center for Biomedical Informatics, Georgetown University Medical Center
Arpad M DanosWashington University School of Medicine in St. Louis
Deborah I RitterBaylor College of Medicine and Texas Children's Hospital
Subha MadhavanInnovation Center for Biomedical Informatics, Georgetown University Medical Center
Subha MadhavanInnovation Center for Biomedical Informatics, Georgetown University Medical Center
Marilyn M LiChildren's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine
Marilyn M LiChildren's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine
Obi L GriffithWashington University School of Medicine in St. Louis
Malachi GriffithWashington University School of Medicine in St. Louis
Gordana RacaChildren's Hospital of Los Angeles
Angshumoy RoyBaylor College of Medicine and Texas Children's Hospital, Baylor College of Medicine, Texas Children's Hospital
  • 1 - 13

Datasets

Release 1.2